The FDA approved the oral retinoid palovarotene (Sohonos) for treating abnormal bone growth associated with fibrodysplasia ossificans progressiva (FOP), drugmaker Ipsen announced on Wednesday.

Achondroplasia, also known as short-limb dwarfism, is associated with neurological symptoms and complications due to narrowing of the skeletal structures surrounding the spinal cord. Despite ...

In a recent study, Associate Professor Makoto Ikeya (Department of Clinical Application) and his team of researchers successfully established a method to generate jawbone-like organoids (mini-organs) ...

Studies by University of Birmingham researchers suggest that a naturally occurring peptide known as PEPITEM (Peptide Inhibitor of Trans-Endothelial Migration), could represent a promising potential ...

AUSTIN, Texas – A novel agent appeared to regulate bone growth signaling in early phase data that stirred hopes it could help osteoporosis and other diseases. In a phase I study, KER-012 did not ...

Growth disorders are conditions that cause faster or slower growth than usual. People with these disorders may have unusually sized limbs and body parts or may be taller or shorter than expected.

Ollier’s disease is a rare condition that causes benign growths, or enchondromas, to develop in the bone cartilage. Typically these growths affect the arm and leg bones. If a person does not develop ...

Osteoporosis — a significant drop in bone density — can lead to fractures and disability if left untreated. Here are ways to ...

Researchers have found that phosphodiesterase 3 (PDE3) inhibitors have the ability to boost long bone growth. Conventionally used to treat heart disease, thrombosis, and asthma, PDE3 inhibitors can ...

In mammals, only 3% of the genome consists of coding genes which, when transcribed into proteins, ensure the biological functions of the organism and the in-utero development of future individuals.